Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia

Mayo Clinic Proceedings
A VellaT O'Brien

Abstract

The advent of treatment with 3-hydroxy-3-methylglutaryl coenzyme A inhibitors has meant that, with a combination of diet and drug therapy, adequate control of serum cholesterol concentrations can be achieved in most patients with hypercholesterolemia. However, some patients, primarily those with familial hypercholesterolemia (FH), may require additional therapy to lower their cholesterol levels. In recent years, low-density lipoprotein (LDL) apheresis has emerged as an effective method of treatment in these patients. The criteria for commencement of LDL apheresis are LDL cholesterol levels of 500 mg/dL or higher for homozygous FH patients, 300 mg/dL or higher for heterozygous FH patients in whom medical therapy has failed, and 200 mg/dL or higher for heterozygous FH patients with documented coronary disease and in whom medical therapy has failed. In addition to cholesterol lowering in patients with FH, other indications for LDL apheresis are emerging. These include its use in the treatment of graft vascular disease in patients receiving cardiac transplants as well as in the treatment of certain glomerulonephritides. This review examines the role of LDL apheresis in the management of lipid disorders and the evidence available to...Continue Reading

References

Jan 1, 1992·Human Mutation·H H HobbsJ L Goldstein
Dec 12, 1992·Lancet·A A KroonA F Stalenhoef
Jul 1, 1992·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·S NaganumaK Ota
Jan 10, 1987·British Medical Journal·S M WoodM D Rawlins
Jan 1, 1987·Biomaterials, Artificial Cells, and Artificial Organs·M OdakaM Shinomiya
Nov 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S YokoyamaA Yamamoto
Jan 1, 1973·Nutrition and Metabolism·A K Khachadurian, S M Uthman
Jun 6, 1981·Lancet·G R Thompson
Oct 1, 1980·The Journal of Pediatrics·J L WitztumG Schonfeld
Jun 1, 1980·British Heart Journal·G R ThompsonR E Steiner
Oct 1, 1980·British Heart Journal·J M AllenC M Oakley
Jul 8, 1995·Lancet·W O Richter, P Schwandt
Dec 1, 1994·The American Journal of Cardiology·B R GordonD R Illingworth
Jan 1, 1994·Chemistry and Physics of Lipids·S KanemitsuE Murakami

❮ Previous
Next ❯

Citations

Apr 25, 2012·Clinical Research in Cardiology Supplements·Volker SchettlerUNKNOWN German Apheresis Working Group
Mar 29, 2008·Atherosclerosis·G R Thompson, UNKNOWN HEART-UK LDL Apheresis Working Group
Oct 16, 2007·International Journal of Clinical Practice·S ArchontakisM Barbir
Aug 16, 2005·The American Journal of Cardiology·Paul Ziajka
Feb 18, 2015·Clinical Research in Cardiology Supplements·P GrützmacherB Öhm
Sep 28, 2016·Case Reports in Neurological Medicine·Allen J Orehek
Aug 18, 2005·Cardiology in Review·Tanaz Kermani, William H Frishman
Jul 8, 2016·Journal of the American Heart Association·Anthony WangPeter P Toth
Apr 10, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Chiang-Ting ChienSu-Ming Hsu
Jul 25, 2009·Current Treatment Options in Cardiovascular Medicine·Puja K MehtaLaurence S Sperling
Feb 6, 2017·Journal of Atherosclerosis and Thrombosis·Mariko Harada-ShibaPamela Foulds
Dec 5, 2019·Biomolecules·Svetlana MikhailovaElena Shakhtshneider
Mar 6, 2003·Atherosclerosis·Gilbert R Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

© 2021 Meta ULC. All rights reserved